Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

Tempus and NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone ...

To kick off our three-part immuno-oncology webinar series, Dr. Cawley will highlight recent advancements driven by next-generation sequencing that may lead to a deeper understanding of the cancer ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...